Global Colorectal Cancer Molecular Diagnostics Competitive Landscape Professional Research Report 2024

Global Colorectal Cancer Molecular Diagnostics Competitive Landscape Professional Research Report 2024



Research Summary

Colorectal cancer molecular diagnostics refers to a set of advanced laboratory techniques used to analyze and detect specific molecular alterations and biomarkers associated with colorectal cancer. These diagnostics focus on understanding the genetic and molecular characteristics of colorectal tumors, helping healthcare professionals make more accurate diagnoses and tailor personalized treatment plans for patients. The tests involve analyzing patient samples, such as tissue or blood, to identify genetic mutations, gene expressions, and other molecular changes that play a role in the development and progression of colorectal cancer. By providing valuable insights into the molecular profile of each patient's cancer, these diagnostics aid in predicting disease prognosis, guiding treatment decisions, and assessing the patient's response to therapy. Colorectal cancer molecular diagnostics have significantly improved our understanding of the disease and contributed to advancements in precision medicine, leading to more targeted and effective therapies for patients with colorectal cancer.

According to DIResearch's in-depth investigation and research, the global Colorectal Cancer Molecular Diagnostics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Colorectal Cancer Molecular Diagnostics include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Colorectal Cancer Molecular Diagnostics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Colorectal Cancer Molecular Diagnostics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Colorectal Cancer Molecular Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Colorectal Cancer Molecular Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Colorectal Cancer Molecular Diagnostics Include:

Roche Diagnostics

Abbott

Thermo Fisher

Qiagen

Illumina

Biomerieux

Bio-Rad

Agilent

Daangene

Amoydx

Colorectal Cancer Molecular Diagnostics Product Segment Include:

Polymerase Chain Reaction PCR

Molecular Hybridization

Biochip

Others

Colorectal Cancer Molecular Diagnostics Product Application Include:

Hospital

Third-Party Testing Agency

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Colorectal Cancer Molecular Diagnostics Industry PESTEL Analysis

Chapter 3: Global Colorectal Cancer Molecular Diagnostics Industry Porter’s Five Forces Analysis

Chapter 4: Global Colorectal Cancer Molecular Diagnostics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Colorectal Cancer Molecular Diagnostics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Colorectal Cancer Molecular Diagnostics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Colorectal Cancer Molecular Diagnostics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Colorectal Cancer Molecular Diagnostics Market Overview
1.1 Product Definition and Statistical Scope
1.2 Colorectal Cancer Molecular Diagnostics Product by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Polymerase Chain Reaction PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Others
1.3 Colorectal Cancer Molecular Diagnostics Product by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Hospital
1.3.3 Third-Party Testing Agency
1.3.4 Others
1.4 Global Colorectal Cancer Molecular Diagnostics Market Revenue Analysis (2019-2030)
1.5 Colorectal Cancer Molecular Diagnostics Market Development Status and Trends
1.5.1 Colorectal Cancer Molecular Diagnostics Industry Development Status Analysis
1.5.2 Colorectal Cancer Molecular Diagnostics Industry Development Trends Analysis
2 Colorectal Cancer Molecular Diagnostics Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Colorectal Cancer Molecular Diagnostics Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Colorectal Cancer Molecular Diagnostics Market Analysis by Regions
4.1 Colorectal Cancer Molecular Diagnostics Overall Market: 2023 VS 2024 VS 2030
4.2 Global Colorectal Cancer Molecular Diagnostics Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Colorectal Cancer Molecular Diagnostics Revenue and Market Share by Region (2019-2024)
4.2.2 Global Colorectal Cancer Molecular Diagnostics Revenue Forecast by Region (2025-2030)
5 Global Colorectal Cancer Molecular Diagnostics Market Size by Type and Application
5.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Type
5.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Application
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Type
6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Application
6.5 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type
7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application
7.5 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Colorectal Cancer Molecular Diagnostics Market Size by Type
8.4 China Colorectal Cancer Molecular Diagnostics Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Colorectal Cancer Molecular Diagnostics Market Size by Type
9.4 APAC (excl. China) Colorectal Cancer Molecular Diagnostics Market Size by Application
9.5 APAC (excl. China) Colorectal Cancer Molecular Diagnostics Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type
10.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application
10.5 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country
10.5.1 Mecixo
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type
11.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application
11.5 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Market Competition by Manufacturers
12.1 Global Colorectal Cancer Molecular Diagnostics Market Revenue by Key Manufacturers (2020-2024)
12.2 Colorectal Cancer Molecular Diagnostics Competitive Landscape Analysis and Market Dynamic
12.2.1 Colorectal Cancer Molecular Diagnostics Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Portfolio
13.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.2 Abbott
13.2.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Abbott Colorectal Cancer Molecular Diagnostics Product Portfolio
13.2.3 Abbott Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.3 Thermo Fisher
13.3.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Portfolio
13.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.4 Qiagen
13.4.1 Qiagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 Qiagen Colorectal Cancer Molecular Diagnostics Product Portfolio
13.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.5 Illumina
13.5.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Illumina Colorectal Cancer Molecular Diagnostics Product Portfolio
13.5.3 Illumina Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.6 Biomerieux
13.6.1 Biomerieux Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Biomerieux Colorectal Cancer Molecular Diagnostics Product Portfolio
13.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.7 Bio-Rad
13.7.1 Bio-Rad Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Portfolio
13.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.8 Agilent
13.8.1 Agilent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Agilent Colorectal Cancer Molecular Diagnostics Product Portfolio
13.8.3 Agilent Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.9 Daangene
13.9.1 Daangene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Daangene Colorectal Cancer Molecular Diagnostics Product Portfolio
13.9.3 Daangene Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
13.10 Amoydx
13.10.1 Amoydx Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.10.2 Amoydx Colorectal Cancer Molecular Diagnostics Product Portfolio
13.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Colorectal Cancer Molecular Diagnostics Industry Chain Analysis
14.2 Colorectal Cancer Molecular Diagnostics Industry Raw Material and Suppliers Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Colorectal Cancer Molecular Diagnostics Typical Downstream Customers
14.4 Colorectal Cancer Molecular Diagnostics Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings